Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Inflammatory Bowel Diseases

Free Subscription 08.12.2025 1 Aliment Pharmacol Ther 3 BMC Gastroenterol 1 Clin Gastroenterol Hepatol 2 Dig Dis Sci 5 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 1 Gastroenterology 5 Inflamm Bowel Dis 8 J Crohns Colitis 1 Mediators Inflamm 3 PLoS One 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. MARACLE B, Quan S, Hamilton P, Shaikh A, et al
   Systematic Review: Efficacy, Safety and Metabolic Outcomes of GLP-1 Receptor Agonists in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Nov 30. doi: 10.1111/apt.70485.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

2. YU Q, Cheng Y, Liu F, Chen Y, et al
   Insights into the treatment of infliximab and vedolizumab in positive PR3-ANCA patients with moderately to severely active ulcerative colitis: multicenter real-world evidence.
   BMC Gastroenterol. 2025 Nov 28. doi: 10.1186/s12876-025-04372.
   PubMed        
   
   
3. QIU K, Ye P
   Analysis of risk factors for Clostridioides difficile infection in patients with ulcerative colitis and development of a predictive nomogram.
   BMC Gastroenterol. 2025 Nov 28. doi: 10.1186/s12876-025-04503.
   PubMed         Abstract available
   
   
4. LIU C, Zhang Y, Wang YJ, Tang YJ, et al
   The potential of lymphocyte-C-reactive protein ratio upon admission to predict therapeutic responsiveness to mesalazine in adult patients with mild-to-moderate active ulcerative colitis.
   BMC Gastroenterol. 2025 Nov 28. doi: 10.1186/s12876-025-04498.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. AKIYAMA S, Park SH, Baek JE, Kanai S, et al
   Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study across Asia.
   Clin Gastroenterol Hepatol. 2025 Dec 1:S1542-3565(25)01004.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. NAPOLITANO D, Bozzetti M, Petrosino F, Cilluffo S, et al
   Self-Efficacy as a Mediator Between Caregiver Burden, Health Literacy, and Contribution to Self-Care in Inflammatory Bowel Disease.
   Dig Dis Sci. 2025 Dec 3. doi: 10.1007/s10620-025-09577.
   PubMed         Abstract available
   
   
7. AL TA'ANI O, Alsakarneh S, Shaukat A, Farraye FA, et al
   Risk of Intestinal and Extraintestinal Malignancies in Inflammatory Bowel Disease With and Without Primary Sclerosing Cholangitis.
   Dig Dis Sci. 2025 Dec 2. doi: 10.1007/s10620-025-09593.
   PubMed         Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

8. BEVIVINO G, Scarozza P, Zerboni G, Iacopini F, et al
   Infliximab-induced pulmonary interstitial disease in a male patient with ulcerative colitis: a case report and review of literature.
   Eur J Gastroenterol Hepatol. 2025;37:1402-1405.
   PubMed         Abstract available
   
   
9. VIAZIS N, Toruner M, Papastergiou V, Mousourakis K, et al
   Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study.
   Eur J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1097/MEG.0000000000003083.
   PubMed         Abstract available
   
   
10. SILBER JL, Norman JM, Kanno T, Crossette EM, et al
    A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in he
    Eur J Gastroenterol Hepatol. 2025 Oct 23. doi: 10.1097/MEG.0000000000003098.
    PubMed         Abstract available
    
    
11. SUN Z, Zhu Z, Yang R, Cao L, et al
    Correlation between infliximab trough levels and postoperative endoscopic recurrence in patients with Crohn's disease.
    Eur J Gastroenterol Hepatol. 2025 Nov 5. doi: 10.1097/MEG.0000000000003088.
    PubMed         Abstract available
    
    
12. WONG ECL, Khan N, Dulai PS, Marshall JK, et al
    Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trial.
    Eur J Gastroenterol Hepatol. 2025 Oct 20. doi: 10.1097/MEG.0000000000003092.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

13. BOULLON-BATALLA N, Fraga-Blanco P, Brunet-Mas E, Calafat M, et al
    Is fertility a challenge in reproductive-age patients with inflammatory bowel disease?
    Gastroenterol Hepatol. 2025 Nov 10:502628. doi: 10.1016/j.gastrohep.2025.502628.
    PubMed        
    
    

    
    Gastroenterology

14. PAN L, Wang G
    Comments on the Role of TL1A/DR3 Signaling and Th9 Cells in Crohn's Disease.
    Gastroenterology. 2025 Nov 27:S0016-5085(25)06585.
    PubMed        
    
    

    
    Inflamm Bowel Dis

15. ZHANG C, Wu J, Liu Z, Luo L, et al
    Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn's Disease: A Multicenter Real-World Retrospective Study.
    Inflamm Bowel Dis. 2025 Nov 29:izaf299. doi: 10.1093.
    PubMed         Abstract available
    
    
16. YAN K, Vuyyuru SK, Taylor A, Figueredo G, et al
    Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResource.
    Inflamm Bowel Dis. 2025 Dec 2:izaf276. doi: 10.1093.
    PubMed         Abstract available
    
    
17. GIDDINGS HL, Ng KS, Solomon MJ, Arzivian A, et al
    Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era.
    Inflamm Bowel Dis. 2025 Dec 2:izaf244. doi: 10.1093.
    PubMed         Abstract available
    
    
18. GU P, Karime C, Fleshner P, Falloon K, et al
    Intestinal Ultrasound for Monitoring Postoperative Crohn's Disease: A Review and Visual Atlas.
    Inflamm Bowel Dis. 2025 Dec 3:izaf248. doi: 10.1093.
    PubMed         Abstract available
    
    
19. TOME J, Alsakarneh S, Hashash JG, Farraye FA, et al
    Evaluating Choice of Biologics for Isolated Small-Bowel Crohn's Disease.
    Inflamm Bowel Dis. 2025 Dec 3:izaf294. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

20. PAPAGEORGIOU N, Haidich AB, Pagkalidou E, Papaemmanouil A, et al
    The global leadership initiative on malnutrition criteria for the diagnosis of malnutrition in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    J Crohns Colitis. 2025 Dec 3:jjaf209. doi: 10.1093.
    PubMed         Abstract available
    
    
21. IKEBATA A, Okabayashi K, Uchino M, Ikeuchi H, et al
    Background Mucosal Inflammation Affects Colorectal Cancer Prognosis in Ulcerative Colitis: A Nationwide, Multicenter Study.
    J Crohns Colitis. 2025 Dec 3:jjaf207. doi: 10.1093.
    PubMed         Abstract available
    
    
22. FERNANDES RG, Khoo E, Jensen Harris H, Gilmore R, et al
    Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfaction.
    J Crohns Colitis. 2025 Dec 2:jjaf221. doi: 10.1093.
    PubMed         Abstract available
    
    
23. SUL HH, Gewehr DM, Kang H, Junior OR, et al
    Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates.
    J Crohns Colitis. 2025 Dec 2:jjaf202. doi: 10.1093.
    PubMed         Abstract available
    
    
24. ANAND E MR, Anandabaskaran S Dr, Pelly T Mr, Hart A Professor, et al
    Real-world evaluation of MRI fistula volume as a radiological biomarker of disease activity in perianal fistulising crohn's disease.
    J Crohns Colitis. 2025 Nov 29:jjaf216. doi: 10.1093.
    PubMed         Abstract available
    
    
25. WEWER MD, Burisch J, Myrelid P, Olen O, et al
    Apples and Oranges? Comparison of Early Ileocolic Resection and Medical Treatment for Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2025 Nov 29:jjaf218. doi: 10.1093.
    PubMed        
    
    
26. ANDERSEN JW, Troelsen FS, Haldrup D, Krogh K, et al
    Cumulative Incidence and Risk Factors for Advanced Neoplasia following Inflammatory Bowel Disease-Related Low-Grade Dysplasia: A Danish Nationwide Cohort Study.
    J Crohns Colitis. 2025 Nov 29:jjaf219. doi: 10.1093.
    PubMed         Abstract available
    
    
27. HONAP S, Debouverie M, Filippi M, Selchen D, et al
    Inflammatory Bowel Disease therapies and Demyelinating Diseases: A Practical Guide to Therapeutic Benefit and Risk.
    J Crohns Colitis. 2025 Nov 29:jjaf215. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Mediators Inflamm

28. XU B, Wu S, Huang J, Lin M, et al
    Gut Microbes Secretions May Trigger Mononuclear Cell Migration and Offer Comorbidity Mechanism Between Inflammatory Bowel Disease and Diabetic Retinopathy.
    Mediators Inflamm. 2025;2025:9894696.
    PubMed         Abstract available
    
    

    
    PLoS One

29. LEET DE, Jin J, Craik CS, Kattah MG, et al
    Post-vaccination SARS-CoV-2 neutralizing antibodies in pregnant women receiving biologics for inflammatory bowel disease.
    PLoS One. 2025;20:e0321242.
    PubMed         Abstract available
    
    
30. ALHASAN R, Alshatti T
    Modifiable risk factors for inflammatory bowel disease in Kuwait: A cross-sectional analysis.
    PLoS One. 2025;20:e0338005.
    PubMed         Abstract available
    
    
31. XU Y, Jiang W, Jiang M, Zhu B, et al
    Second-line treatment strategies of ulcerative colitis after conventional therapy failure: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0337222.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

32. LI VOTI R, Macaluso FS, Renna S, Casa A, et al
    Post-colectomy enteritis with ulcerative colitis: a rare but severe inflammatory condition.
    Scand J Gastroenterol. 2025 Dec 4:1-7. doi: 10.1080/00365521.2025.2597266.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.